Email Updates
Organizational Policy/Guidelines
ASHP Guidelines on Preventing Diversion of Controlled Substances.
December 14, 2022
Clark J, Fera T, Fortier CR, et al. Am J Health Syst Pharm. 2022;79(24):2279-2306.
Drug diversion is a system issue that has the potential to disrupt patient access to safe, reliable medications and result in harm. These guidelines offer a structured approach for organizations to develop and implement drug diversion prevention efforts. The strategies submitted focus on foundational, organizational, and individual prevention actions that target risk points across the medication use process such as storage, prescribing, and waste disposal.
